The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to see if women presenting for emergency contraception (EC) and choose the copper intrauterine device (IUD) will have fewer unplanned pregnancies in the next year compared to women who choose oral levonorgestrel for EC. The study will also compare use of an effective method of contraception in the year after they received EC.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Utah
• Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Society of Family Planning
• Treatments: Copper; Levonorgestrel

Criteria

Inclusion Criteria:

• Women 18-30 years old,

• in need of emergency contraception (had unprotected intercourse within 120 hours),

• willing to give consent for participation in research,

• willing to comply with study requirements, and

• accessible by telephone.

Participants selecting the IUD need to identify themselves as desiring long-term contraception.

Exclusion Criteria:

• Current pregnancy

• Had pelvic inflammatory disease or septic abortion within the past 3 months or had gonorrhea or chlamydia infection in the last 60 days

• Current behavior suggesting a high risk for pelvic inflammatory disease

• Allergy to copper or Wilson's disease (for participants selecting the copper IUD) or allergy to levonorgestrel (for participants selecting oral levonorgestrel)

• Abnormalities of the uterus that distort the uterine cavity

• Mucopurulent cervicitis

• A previously placed IUD that has not been removed

• Genital bleeding of an unknown etiology

• Ovarian, cervical, or endometrial cancer

• Small uterine cavity (< 6cm)